Category Archives: EP and UK Practice

Recent Rulings of the European Court of Justice on SPCs

Posted on January 4, 2012 by Warren Woessner

Attached you will find the newsletter from DHS Patentanwalts GmbH, provided to us by Dr. Stefan Danner. In the last few months, the European Court of Justice (ECJ) has handed down several decisions relating to the grant and validity of … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment

HUMAN GENOME SCIENCES v. ELI LILLY – Increased European Harmony?

Posted on December 2, 2011 by Warren Woessner

By Paul Cole, European Patent Attorney, Lucas & Co – Warlingham, UK Judgement – Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) The above proceedings relate to European Patent (UK) 0,939,804 concerning a new  human  protein called Neutrokine-α. … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , | 1 Comment

EPO Ruling On Inventiveness Of Drug Polymorphs

Posted on November 5, 2011 by Warren Woessner

Thank you to Dr. Stefan Danner, a German and European Patent Attorney at DHS Patentanwaltsgesellschaft mbH in Munich for letting us post the current issue of the biotech IP newsletter dealing with the recent EPO decision concerning the patentability of … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , , , , | Leave a comment

Decision of the EPO Enlarged Board of Appeal – Sexual Crossing and Selection of Plants is Not Patentable Even When Using DNA Markers

Posted on May 18, 2011 by Warren Woessner

The following is a contribution from Verena Simpson PhD of Zacco Denmark A/S. G 0001/08 The core of the Decision 1. A non-microbiological process for the production of plants which contains or consists of the steps of sexually crossing the … Continue reading →

Posted in EP and UK Practice | Tagged , , , , | Leave a comment